Hepatology · 2017 · 86 citations · 30 references
Veterinary MedicineMolecular BiologyPathobiologyCell SignalingHepatologyInflammationAlcohol-related Liver ToxicityChronic Liver DiseaseHepatic ImpairmentHepatic PathophysiologyLiver DiseaseLiver PhysiologyAlcohol-related Liver InjuryAlcoholic Liver Disease ProgressionAlcoholic Liver Disease SteatosisKupffer Cell FunctionKupffer CellsM2 Macrophage PhenotypesM2-like Macrophage ActivationMacrophage Polarization
Nogo-B (Reticulon 4B) is an endoplasmic reticulum (ER) resident protein that regulates ER structure and function. Because ER stress is known to induce M2 macrophage polarization, we examined whether Nogo-B regulates M1/M2 polarization of Kupffer cells and alters the pathogenesis of alcoholic liver disease (ALD). M1 and M2 phenotypes were assessed in relation to Nogo-B expression and disease severity in liver specimens from ALD patients (NCT01875211). Liver specimens from wild-type (WT) and Nogo-B knockout (KO) mice fed a control or Lieber-DeCarli ethanol liquid diet (5% ethanol) for 6 weeks were analyzed for liver injury and steatosis. Kupffer cells isolated from WT and Nogo-B KO mice were assessed for M1 and M2 activation. A significant positive correlation was observed between Nogo-B positive Kupffer cells and disease severity in ALD patients (n = 30, r = 0.66, P = 0.048). Furthermore, Nogo-B-positive Kupffer cells were correlated with M1 activation (inducible nitric oxide synthase) (r = 0.50, P = 0.05) and negatively with markers of M2 status (CD163) (r = -0.48, P = 0.07) in these patients. WT mice exhibited significantly increased liver injury (P < 0.05) and higher hepatic triglyceride levels (P < 0.01) compared with Nogo-B KO mice in response to chronic ethanol feeding. Nogo-B in Kupffer cells promoted M1 polarization, whereas absence of Nogo-B increased ER stress and M2 polarization in Kupffer cells. CONCLUSION: Nogo-B is permissive of M1 polarization of Kupffer cells, thereby accentuating liver injury in ALD in humans and mice. Nogo-B in Kupffer cells may represent a new therapeutic target for ALD. (Hepatology 2017;65:1720-1734).
30
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Adeline Bertola, Stephanie Mathews, Sung Hwan Ki et al. · Nature Protocols · 2013 · 1.2K citations · Full text
Medicine, Neurobiology, Neuroscience +12
A Class of Membrane Proteins Shaping the Tubular Endoplasmic Reticulum
Gia K. Voeltz, William A. Prinz, Yoko Shibata et al. · Cell · 2006 · 1.2K citations · Full text
Alexandr Parlesak, Christian Schäfer, Tatjana Schütz et al. · Journal of Hepatology · 2000 · 636 citations
Medicine, Pharmacology, Toxicology +17